You are here

Femoral neck osteopenia in patients with inflammatory bowel disease.

Related Articles Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 1998 Sep;93(9):1483-90 Authors: Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D Abstract OBJECTIVE: The mechanism of bone loss in patients with inflammatory bowel disease (IBD) is not completely understood. The aim of this study was to assess indices of bone turnover and bone mineral density (BMD) in the lumbar spine and femoral neck in IBD patients. METHODS: Sixty-three patients with Crohn’s disease and 41 with ulcerative colitis were studied. Serum bone-specific alkaline…

Read More

Review article: osteoporosis, corticosteroids and inflammatory bowel disease.

Related Articles Review article: osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther. 1995 Jun;9(3):237-50 Authors: Compston JE Abstract Osteoporosis is a serious complication of inflammatory bowel disease which has not received adequate recognition despite its high prevalence and potentially devastating clinical effects. Its pathogenesis remains poorly defined although corticosteroid therapy and sex hormone deficiency are likely to play a major role. Recent advances in the diagnosis and management of osteoporosis have facilitated early detection of bone loss and identified means by which this may be prevented. Bone density measurements…

Read More

Osteoporosis in patients with inflammatory bowel disease.

Related Articles Osteoporosis in patients with inflammatory bowel disease. Gut. 1987 Apr;28(4):410-5 Authors: Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, Reid EM, Rhodes J Abstract Bone mineral content in spinal trabecular and peripheral cortical bone was measured in 75 unselected patients with small and/or large intestinal inflammatory bowel disease. Osteoporosis, defined as a bone mineral content greater than 2 SD below the age and sex matched normal mean value was present in 23 patients (30.6%). Three amenorrhoeic females aged 34, 38, and 42 years had…

Read More

Osteoporosis and determinants of bone density in patients with Crohn’s disease.

Related Articles Osteoporosis and determinants of bone density in patients with Crohn’s disease. Dig Dis Sci. 1998 Nov;43(11):2500-6 Authors: Robinson RJ, al-Azzawi F, Iqbal SJ, Kryswcki T, Almond L, Abrams K, Mayberry JF Abstract Low bone mineral density (BMD) is common in patients with Crohn’s disease; however, the pathogenesis of bone loss and risk factors for osteoporosis are not established. Our aim was to evaluate the clinical, dietary, and nutritional determinants of BMD in Crohn’s disease. A cross-sectional analysis of 117 patients with Crohn’s disease was undertaken. All patients underwent…

Read More

Prevention and treatment of osteoporosis in patients with inflammatory bowel disease.

Related Articles Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Am J Gastroenterol. 1999 Apr;94(4):878-83 Authors: Valentine JF, Sninsky CA Abstract Osteopenia or osteoporosis is common in patients with inflammatory bowel disease. The use of corticosteroids contributes to the decline in bone loss; however, osteoporosis may develop in patients with inflammatory bowel disease independent of corticosteroid use. Risk factors for the development of low bone mass in patients with inflammatory bowel disease include the general risk factors for osteoporosis as well as additional factors such as the…

Read More

Evolution of osteopenia in inflammatory bowel disease.

Related Articles Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol. 1999 May;94(5):1292-7 Authors: Dinca M, Fries W, Luisetto G, Peccolo F, Bottega F, Leone L, Naccarato R, Martin A Abstract OBJECTIVE: Our aim was the assessment of frequency and evolution of osteopenia in patients with inflammatory bowel disease and identification of related factors. METHODS: Bone mineral density (BMD) of the lumbar spine was measured in 54 patients with Crohn’s disease (CD) and in 49 patients with ulcerative colitis (UC) and was repeated after a mean observation period of…

Read More

Low serum and bone vitamin K status in patients with longstanding Crohn’s disease: another pathogenetic factor of osteoporosis in Crohn’s disease?

Related Articles Low serum and bone vitamin K status in patients with longstanding Crohn’s disease: another pathogenetic factor of osteoporosis in Crohn’s disease? Gut. 2001 Apr;48(4):473-7 Authors: Schoon EJ, Müller MC, Vermeer C, Schurgers LJ, Brummer RJ, Stockbrügger RW Abstract BACKGROUND: A high prevalence of osteoporosis is reported in Crohn’s disease. The pathogenesis is not completely understood but is probably multifactorial. Longstanding Crohn’s disease is associated with a deficiency of fat soluble vitamins, among them vitamin K. Vitamin K is a cofactor in the carboxylation of osteocalcin, a protein essential…

Read More
<< Go Back